The global BCL-2 like protein market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). BCL-2, also known as B Cell Lymphoma 2, is a protein encoding gene belonging to the B cell lymphoma family. The market growth is majorly attributable to the growth is the significant prevalence of diffuse B cell lymphoma, a common type of non-Hodgkin lymphoma. For instance, according to an article by Lymphoma Research Foundation in 2019, in the US, DLBCL accounted for 22% of new diagnosed B cell lymphoma cases. Around 18,000 people globally are diagnosed with DLBCL each year. 

Adding to this, the disease affects people over 60 years of age. According to the American Cancer Society in 2019, an estimated 20,720 people were diagnosed with chronic lymphocytic lymphoma. Moreover, 90% of the people diagnosed with this form of lymphoma are estimated to affect people above 50 years of age. In the US, 2,220 men and 1,710 women are expected to be suffering from chronic lymphocytic lymphoma every year. Moreover, as per the American Cancer Society, about 3,930 mortalities were anticipated to take place in 2019. Further, there are various inhibitor drugs being approved in the market that spur the market growth. For instance, Venetoclax is the only and fist approved FDA BCL-2 inhibitor drug for chronic lymphocytic lymphoma patients. Although various clinical trials are being carried out for the development of new BCL-2 inhibitors.

Market Coverage

• The market number available for – 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

• Segment Covered- 

o By Type

o By Application

• Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape:  AbbVie Inc., and Takeda Pharmaceutical Company Ltd., among others.

Key questions addressed by the report

• What is the market growth rate?

• Which segment and region dominate the market in the base year?

• Which segment and region will project the fastest growth in the market?

• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?

• How are players addressing challenges to sustain growth?

• Where is the investment opportunity?

Global BCL-2-Like Protein Market Report by Segment

By Type

• BCL-2-Like Protein 1
• BCL-2-Like Protein 2
• BCL-2-Like Protein 4
• Others

By Application

• Hospital
• Clinic
• Others

Global BCL-2-Like Protein Market Report by Region

North America       

• US

• Canada

Europe

• Germany

• UK

• France

• Spain

• Italy

• Rest of Europe

Asia-Pacific    

• China

• Japan

• India

• Rest of Asia-Pacific

Rest of the World

• Latin America

• Middle East and Africa